Chicago Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.27M | Sell |
11,787
-427
| -3% | -$146K | 0.1% | 99 |
|
|
2026
Q1 | $4.3M | Buy |
12,214
+167
| +1% | +$59.5K | 0.12% | 90 |
|
|
2025
Q4 | $3.94M | Buy |
12,047
+14
| +0.1% | +$4.44K | 0.1% | 93 |
|
|
2025
Q3 | $3.4M | Sell |
12,033
-872
| -7% | -$253K | 0.08% | 106 |
|
|
2025
Q2 | $3.6M | Sell |
12,905
-263
| -2% | -$74.5K | 0.09% | 102 |
|
|
2025
Q1 | $4.1M | Sell |
13,168
-1,212
| -8% | -$358K | 0.12% | 91 |
|
|
2024
Q4 | $3.75M | Buy |
14,380
+16
| +0.1% | +$4.75K | 0.1% | 97 |
|
|
2024
Q3 | $4.63M | Sell |
14,364
-3,987
| -22% | -$1.3M | 0.13% | 87 |
|
|
2024
Q2 | $5.73M | Sell |
18,351
-567
| -3% | -$167K | 0.17% | 80 |
|
|
2024
Q1 | $5.38M | Buy |
18,918
+308
| +2% | +$90.1K | 0.16% | 73 |
|
|
2023
Q4 | $5.36M | Buy |
18,610
+6,407
| +53% | +$1.75M | 0.19% | 70 |
|
|
2023
Q3 | $3.28M | Hold |
12,203
| – | – | 0.15% | 64 |
|
|
2023
Q2 | $2.71M | Hold |
12,203
| – | – | 0.12% | 71 |
|
|
2023
Q1 | $2.95M | Sell |
12,203
-113
| -0.9% | -$27.7K | 0.15% | 67 |
|
|
2022
Q4 | $3.23M | Hold |
12,316
| – | – | 0.18% | 65 |
|
|
2022
Q3 | $2.78M | Buy |
12,316
+5
| +0% | +$1.21K | 0.16% | 68 |
|
|
2022
Q2 | $3M | Buy |
12,311
+250
| +2% | +$61.3K | 0.17% | 67 |
|
|
2022
Q1 | $2.92M | Buy |
12,061
+600
| +5% | +$138K | 0.13% | 71 |
|
|
2021
Q4 | $2.58M | Hold |
11,461
| – | – | 0.1% | 79 |
|
|
2021
Q3 | $2.44M | Sell |
11,461
-300
| -3% | -$69K | 0.09% | 78 |
|
|
2021
Q2 | $2.87M | Sell |
11,761
-580
| -5% | -$143K | 0.11% | 71 |
|
|
2021
Q1 | $3.07M | Hold |
12,341
| – | – | 0.13% | 66 |
|
|
2020
Q4 | $2.84M | Buy |
12,341
+30
| +0.2% | +$6.92K | 0.13% | 67 |
|
|
2020
Q3 | $3.13M | Hold |
12,311
| – | – | 0.16% | 67 |
|
|
2020
Q2 | $2.9M | Buy |
12,311
+2,352
| +24% | +$537K | 0.17% | 68 |
|
|
2020
Q1 | $2.02M | Hold |
9,959
| – | – | 0.16% | 71 |
|
|
2019
Q4 | $2.4M | Sell |
9,959
-70
| -0.7% | -$15.4K | 0.15% | 72 |
|
|
2019
Q3 | $1.94M | Buy |
10,029
+170
| +2% | +$32.6K | 0.13% | 76 |
|
|
2019
Q2 | $1.82M | Buy |
9,859
+1,811
| +23% | +$324K | 0.12% | 80 |
|
|
2019
Q1 | $1.53M | Sell |
8,048
-2,114
| -21% | -$404K | 0.1% | 89 |
|
|
2018
Q4 | $1.98M | Sell |
10,162
-288
| -3% | -$56.2K | 0.16% | 71 |
|
|
2018
Q3 | $2.17M | Sell |
10,450
-450
| -4% | -$88.7K | 0.15% | 68 |
|
|
2018
Q2 | $2.01M | Buy |
10,900
+2,707
| +33% | +$479K | 0.16% | 70 |
|
|
2018
Q1 | $1.4M | Buy |
+8,193
| New | +$1.5M | 0.19% | 68 |
|
Other funds holding AMGN
FFM
SP
Chicago Capital's AMGN Position: Q2 2026 in Review
Chicago Capital reduced its Amgen (AMGN) stake by 3.5% in Q2 2026, selling an estimated $146K and leaving 11,787 shares worth $4.27M. The position accounts for 0.1% of the portfolio, ranked #99.
Chicago Capital first reported a position in AMGN in Q1 2018 and has held it in 34 quarters since. The position peaked at $5.73M in Q2 2024. 1,282 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Chicago Capital held 11,787 shares of Amgen worth $4.27M as of Q2 2026.
- Chicago Capital sold 427 Amgen shares in Q2 2026, an estimated $146K.
- Amgen made up 0.1% of Chicago Capital's portfolio in Q2 2026, its #99 holding.
- Chicago Capital first reported a position in Amgen in Q1 2018 and has held it in 34 quarters since.
- Chicago Capital's Amgen position peaked at $5.73M in Q2 2024.
- 1,282 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Chicago Capital's 13F filing for Q2 2026, filed 28 Jul 2026.